By Sheri Kasprzak
New York, April 5 - Naturewell, Inc. said it entered into an equity line with Dutchess Private Equities Fund II, LP.
Over the next three years, Dutchess may buy shares of Naturewell at 95% of the lowest closing bid price for the five trading days before notice of a draw.
There is a limit per draw of either $150,000 or 200% of the average daily volume of the company's stock for the 10 trading days before a draw multiplied by the average of the three daily closing bid prices before the draw.
Naturewell, based in San Diego, is a research and development company focused on homeopathic treatments.
| Issuer: | Naturewell, Inc.
|
| Issue: | Equity line
|
| Amount: | $10 million
|
| Tenor: | Three years
|
| Price: | 95% of the lowest closing bid price for the five trading days before notice of a draw
|
| Warrants: | No
|
| Investor: | Dutchess Private Equities Fund II, LP
|
| Settlement date: | March 31
|
| Stock symbol: | OTCBB: NAWL
|
| Stock price: | $0.0035 at close March 31
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
